🇺🇸 FDA

Company profile · Sponsor

Janux

Janux Therapeutics

JANX · NYSE pharma SAN DIEGO, CA, USA
Pipeline
4
Drugs
0
Patents
2

Quick answer

Janux (JANX) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker JANX
Exchange NYSE
Company type pharma
Headquarters SAN DIEGO, CA, USA
SEC CIK 0001817713

Pipeline (4)

Search pipeline →

  1. JANX007

    Janux

    Prostate Cancer

    phase 1 mab active

    1 trial

  2. JANX008

    Janux

    Non-Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  3. JANX011

    Janux

    Autoimmune

    phase 1 small molecule active

    1 trial

  4. JANX014

    Janux

    Prostate Cancer

    phase 1 mab active

    1 trial

Patents (2)

Search patents →

  1. US 12161724

    Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11512113

    Cleavable linker compositions and methods

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Janux?

Janux (JANX) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does Janux sponsor?

We track 4 ClinicalTrials.gov-linked programs for Janux, including JANX007 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Janux company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.